Free Trial
→ You’re Being LIED To About The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free XPEV Stock Alerts

XPENG (XPEV) Financials

XPENG logo
$15.74 -0.19 (-1.22%)
As of 11:23 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for XPENG

Annual Income Statements for XPENG

This table shows XPENG's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -328 -667 -752 -763 -1,325 -1,461 -793 -163
Consolidated Net Income / (Loss)		 -204 -530 -420 -763 -1,325 -1,461 -793 -163
Net Income / (Loss) Continuing Operations		 -204 -530 -420 -763 -1,325 -1,461 -793 -163
Total Pre-Tax Income 		-204 -530 -420 -759 -1,322 -1,464 -799 -165
Total Operating Income		 -247 -543 -660 -1,032 -1,262 -1,534 -912 -396
Total Gross Profit		 -0.34 -80 41 412 448 64 801 2,070
Total Revenue		 1.41 333 899 3,293 3,894 4,321 5,599 10,971
Operating Revenue		 1.41 333 899 3,293 3,894 4,321 5,599 10,971
Total Cost of Revenue		 1.76 413 858 2,882 3,446 4,257 4,798 8,901
Operating Cost of Revenue		 1.76 413 858 2,882 3,446 4,257 4,798 8,901
Total Operating Expenses		 246 463 701 1,444 1,710 1,597 1,713 2,466
Selling, General & Admin Expense		 94 167 449 833 970 924 941 1,344
Research & Development Expense		 153 297 265 646 756 743 885 1,357
Other Operating Expenses / (Income)		 -0.22 -1.77 -13 -34 -16 -70 -113 -235
Total Other Income / (Expense), net		 43 13 240 273 -60 70 113 231
Interest Expense		 0.85 4.60 3.45 8.68 19 38 47 54
Interest & Investment Income		 9.52 13 20 209 157 146 152 238
Other Income / (Expense), net		 34 4.61 223 73 -198 -38 8.03 47
Income Tax Expense		 0.00 0.00 0.19 4.08 3.59 5.18 -9.56 1.94
Other Gains / (Losses), net		 - - 0.00 0.00 0.60 7.71 -3.98 4.42
Basic Earnings per Share		 ($6.83) ($13.29) ($6.48) ($2.96) ($5.34) ($5.96) ($3.06) ($0.60)
Weighted Average Basic Shares Outstanding		 330.18M 349.45M 754.27M 1.64B 1.71B 1.74B 1.89B 1.90B
Diluted Earnings per Share		 ($6.83) ($13.29) ($6.48) ($2.96) ($5.34) ($5.96) ($3.06) ($0.60)
Weighted Average Diluted Shares Outstanding		 330.18M 349.45M 754.27M 1.64B 1.71B 1.74B 1.89B 1.90B
Weighted Average Basic & Diluted Shares Outstanding		 330.18M 349.45M 754.27M 1.64B 1.72B 1.89B 1.90B 1.91B

Quarterly Income Statements for XPENG

No quarterly income statements for XPENG are available.

Annual Cash Flow Statements for XPENG

This table details how cash moves in and out of XPENG's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 223 111 4,481 -3,067 379 1,352 -356 206
Net Cash From Operating Activities		 -229 -512 -21 -172 -1,194 135 -276 1,181
Net Cash From Continuing Operating Activities		 -229 -512 -21 -172 -1,194 135 -276 1,181
Net Income / (Loss) Continuing Operations		 -204 -530 -420 -763 -1,325 -1,461 -793 -163
Consolidated Net Income / (Loss)		 -204 -530 -420 -763 -1,325 -1,461 -793 -163
Depreciation Expense		 7.79 18 47 90 133 232 215 258
Amortization Expense		 6.13 15 21 42 72 65 137 169
Non-Cash Adjustments To Reconcile Net Income		 -39 -21 -112 -453 205 285 -194 1,146
Changes in Operating Assets and Liabilities, net		 -0.44 7.27 444 913 -278 1,014 359 -229
Net Cash From Investing Activities		 -528 106 -678 -5,190 703 89 -172 -1,049
Net Cash From Continuing Investing Activities		 -528 106 -678 -5,190 703 89 -172 -1,049
Purchase of Property, Plant & Equipment		 -112 -263 -124 -361 -620 -295 -305 -451
Acquisitions		 -6.91 -25 -66 -57 -14 -89 -27 -27
Purchase of Investments		 0.00 0.00 -0.15 -151 -90 -27 -20 -15
Sale of Property, Plant & Equipment		 0.07 0.04 3.77 3.79 11 1.18 23 7.50
Divestitures		 0.00 0.00 - 0.00 0.00 96 0.00 0.00
Sale and/or Maturity of Investments		 -382 383 -509 -3,861 1,436 216 85 -252
Other Investing Activities, net		 -28 12 17 -765 -20 186 71 -311
Net Cash From Financing Activities		 980 516 5,280 2,295 870 1,129 92 74
Net Cash From Continuing Financing Activities		 980 516 5,280 2,295 870 1,129 92 74
Repayment of Debt		 -47 -107 -376 -154 -115 -727 -1,304 -1,186
Issuance of Debt		 175 233 322 392 986 1,165 1,468 1,268
Other Financing Activities, net		 0.00 0.00 2,459 -5.79 -0.27 691 -73 -8.84
Cash Interest Paid		 4.32 3.79 12 20 24 43 64 72
Cash Income Taxes Paid		 - - - 0.00 5.23 3.62 4.61 2.47

Quarterly Cash Flow Statements for XPENG

No quarterly cash flow statements for XPENG are available.

Annual Balance Sheets for XPENG

This table presents XPENG's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,328 6,876 10,302 10,365 11,854 11,331 14,752
Total Current Assets		 712 6,103 7,663 6,311 7,679 6,814 9,045
Cash & Equivalents		 280 4,493 1,730 2,118 2,976 2,546 2,478
Restricted Cash		 66 359 96 15 447 447 996
Short-Term Investments		 59 434 445 183 110 103 460
Note & Lease Receivable		 - - - - - 0.00 0.00
Accounts Receivable		 77 174 420 568 384 336 286
Inventories, net		 65 207 418 656 778 762 1,484
Prepaid Expenses		 156 263 353 358 351 430 757
Other Current Assets		 3.25 175 4,202 2,413 2,633 2,190 2,583
Plant, Property, & Equipment, net		 464 474 851 1,538 1,543 1,578 1,934
Total Noncurrent Assets		 137 299 1,788 2,517 2,632 2,938 3,773
Long-Term Investments		 0.00 0.15 243 333 402 473 571
Noncurrent Note & Lease Receivables		 - 61 292 317 426 609 929
Intangible Assets		 17 93 138 151 697 632 608
Other Noncurrent Operating Assets		 120 145 1,115 1,715 1,107 1,225 1,665
Total Liabilities & Shareholders' Equity		 1,328 6,876 10,302 10,365 11,854 11,331 14,752
Total Liabilities		 917 1,581 3,688 5,014 6,737 7,046 10,409
Total Current Liabilities		 473 1,205 2,827 3,496 5,086 5,461 8,310
Short-Term Debt		 69 27 0.00 461 740 886 875
Accounts Payable		 137 788 1,944 2,062 3,128 2,080 2,574
Accrued Expenses		 252 347 755 810 1,068 1,185 1,793
Current Deferred Revenue		 2.35 25 66 56 89 175 209
Current Deferred & Payable Income Tax Liabilities		 0.00 0.19 3.57 4.01 0.81 1.99 6.39
Other Current Liabilities		 13 18 59 103 61 1,134 2,852
Total Noncurrent Liabilities		 444 375 862 1,517 1,651 1,585 2,099
Long-Term Debt		 243 253 263 669 796 776 942
Noncurrent Deferred Revenue		 9.92 22 75 101 94 113 172
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - 0.00 57 47 47
Other Noncurrent Operating Liabilities		 191 100 524 748 704 649 937
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -981 5,295 6,614 5,352 5,117 4,285 4,343
Total Preferred & Common Equity		 -981 5,295 6,614 5,352 5,117 4,285 4,343
Total Common Equity		 -981 5,295 6,614 5,352 5,117 4,285 4,343
Common Stock		 0.00 7,149 9,412 8,799 9,887 9,682 10,187
Retained Earnings		 -980 -1,741 -2,541 -3,673 -5,037 -5,697 -6,116
Accumulated Other Comprehensive Income / (Loss)		 -0.85 -112 -259 224 258 287 252
Other Equity Adjustments		 - 0.00 0.95 0.93 8.46 13 20

Quarterly Balance Sheets for XPENG

No quarterly balance sheets for XPENG are available.

Annual Metrics And Ratios for XPENG

This table displays calculated financial ratios and metrics derived from XPENG's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - 1,909,755,657.00
DEI Adjusted Shares Outstanding		 - - - - - - - 1,909,755,657.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - -0.09
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 23,490.77% 169.72% 266.40% 18.22% 10.97% 29.58% 95.95%
EBITDA Growth		 0.00% -154.93% 26.89% -124.08% -51.57% -1.57% 56.74% 114.19%
EBIT Growth		 0.00% -153.54% 18.80% -119.62% -52.12% -7.67% 42.48% 61.40%
NOPAT Growth		 0.00% -120.06% -21.67% -56.34% -22.25% -21.52% 40.53% 56.55%
Net Income Growth		 0.00% -160.33% 20.72% -81.61% -73.63% -10.29% 45.72% 79.46%
EPS Growth		 0.00% -94.58% 51.24% 54.32% -80.41% -11.61% 48.66% 80.39%
Operating Cash Flow Growth		 0.00% -123.46% 95.80% -699.03% -594.89% 111.28% -304.71% 528.36%
Free Cash Flow Firm Growth		 0.00% 0.00% 32.52% -951.45% 92.64% 111.64% -826.01% 249.39%
Invested Capital Growth		 0.00% 0.00% -2.08% 1,405.32% -12.16% -29.09% -12.52% -30.41%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 -24.33% -24.05% 4.55% 12.50% 11.50% 1.47% 14.30% 18.86%
EBITDA Margin		 -14,040.24% -151.72% -41.12% -25.15% -32.24% -29.51% -9.85% 0.71%
Operating Margin		 -17,459.65% -162.87% -73.47% -31.35% -32.42% -35.50% -16.29% -3.61%
EBIT Margin		 -15,025.52% -161.49% -48.62% -29.14% -37.50% -36.38% -16.15% -3.18%
Profit (Net Income) Margin		 -14,411.94% -159.04% -46.75% -23.17% -34.03% -33.82% -14.17% -1.49%
Tax Burden Percent		 100.00% 100.00% 100.04% 100.54% 100.23% 99.83% 99.30% 98.50%
Interest Burden Percent		 95.92% 98.48% 96.11% 79.09% 90.55% 93.13% 88.35% 47.40%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -256.73% -157.82% -31.07% -21.56% -32.78% -25.06% -13.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 4.12% -159.46% -29.95% 1.86% -12.99% -17.87% -18.74%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -1.15% 143.09% 18.25% -0.59% 4.86% 8.19% 9.98%
Return on Equity (ROE)		 0.00% -257.88% -14.73% -12.82% -22.15% -27.92% -16.88% -3.78%
Cash Return on Invested Capital (CROIC)		 0.00% -456.73% -155.72% -206.15% -8.61% 1.25% -11.71% 22.10%
Operating Return on Assets (OROA)		 0.00% -40.52% -10.65% -11.17% -14.13% -14.15% -7.80% -2.68%
Return on Assets (ROA)		 0.00% -39.90% -10.24% -8.88% -12.82% -13.15% -6.84% -1.25%
Return on Common Equity (ROCE)		 0.00% 615.24% -11.14% -12.82% -22.15% -27.92% -16.88% -3.78%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 54.05% -7.93% -11.54% -24.76% -28.56% -18.51% 0.00%
Net Operating Profit after Tax (NOPAT)		 -173 -380 -462 -723 -884 -1,074 -639 -277
NOPAT Margin		 -12,221.76% -114.01% -51.43% -21.94% -22.69% -24.85% -11.40% -2.53%
Net Nonoperating Expense Percent (NNEP)		 0.00% -260.85% 1.64% -1.11% -23.42% -19.79% -7.19% 4.98%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - -10.74% -4.50%
Cost of Revenue to Revenue		 124.33% 124.05% 95.45% 87.50% 88.50% 98.53% 85.70% 81.14%
SG&A Expenses to Revenue		 6,620.04% 50.17% 49.97% 25.28% 24.90% 21.38% 16.81% 12.25%
R&D to Revenue		 10,830.61% 89.18% 29.53% 19.60% 19.42% 17.20% 15.80% 12.37%
Operating Expenses to Revenue		 17,435.33% 138.83% 78.02% 43.84% 43.92% 36.97% 30.60% 22.48%
Earnings before Interest and Taxes (EBIT)		 -212 -538 -437 -960 -1,460 -1,572 -904 -349
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -198 -506 -370 -828 -1,255 -1,275 -552 78
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.81 6.01 1.59 2.46 2.60 4.43
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.82 6.14 1.64 2.85 3.05 5.16
Price to Revenue (P/Rev)		 1,058.95 4.49 4.75 12.07 2.18 2.91 1.99 1.76
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 9.44 0.00 8.60 1.82 3.78 3.89 10.01
Enterprise Value to Revenue (EV/Rev)		 0.00 8.39 0.00 11.39 1.79 2.38 1.65 1.51
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 211.71
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 76.37 0.00 14.03
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 250.35 0.00 37.19
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.76 0.05 0.04 0.21 0.30 0.39 0.42
Long-Term Debt to Equity		 0.00 0.59 0.05 0.04 0.13 0.16 0.18 0.22
Financial Leverage		 0.00 -0.28 -0.90 -0.61 -0.32 -0.37 -0.46 -0.53
Leverage Ratio		 0.00 3.23 1.44 1.44 1.73 2.12 2.47 3.02
Compound Leverage Factor		 0.00 3.18 1.38 1.14 1.56 1.98 2.18 1.43
Debt to Total Capital		 0.00% 43.11% 5.02% 3.82% 17.43% 23.09% 27.95% 29.50%
Short-Term Debt to Total Capital		 0.00% 9.54% 0.48% 0.00% 7.12% 11.12% 14.90% 14.21%
Long-Term Debt to Total Capital		 0.00% 33.58% 4.54% 3.82% 10.32% 11.96% 13.05% 15.30%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 192.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -135.71% 94.98% 96.18% 82.57% 76.91% 72.05% 70.50%
Debt to EBITDA		 0.00 -0.62 -0.76 -0.32 -0.90 -1.20 -3.01 23.22
Net Debt to EBITDA		 0.00 0.18 13.54 2.72 1.21 1.80 3.43 -34.35
Long-Term Debt to EBITDA		 0.00 -0.48 -0.68 -0.32 -0.53 -0.62 -1.41 12.04
Debt to NOPAT		 0.00 -0.82 -0.60 -0.36 -1.28 -1.43 -2.60 -6.55
Net Debt to NOPAT		 0.00 0.24 10.83 3.11 1.72 2.13 2.96 9.69
Long-Term Debt to NOPAT		 0.00 -0.64 -0.55 -0.36 -0.76 -0.74 -1.22 -3.40
Altman Z-Score		 0.00 -0.92 2.04 6.70 0.76 0.71 0.62 1.26
Noncontrolling Interest Sharing Ratio		 0.00% 338.57% 24.39% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 1.50 5.06 2.71 1.81 1.51 1.25 1.09
Quick Ratio		 0.00 0.88 4.23 0.92 0.82 0.68 0.55 0.39
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -676 -456 -4,796 -353 41 -298 446
Operating Cash Flow to CapEx		 -204.29% -194.55% -17.88% -48.10% -196.07% 45.79% -97.85% 266.11%
Free Cash Flow to Firm to Interest Expense		 0.00 -147.05 -132.09 -552.31 -18.42 1.09 -6.33 8.20
Operating Cash Flow to Interest Expense		 -270.13 -111.28 -6.23 -19.78 -62.28 3.56 -5.85 21.74
Operating Cash Flow Less CapEx to Interest Expense		 -402.36 -168.48 -41.04 -60.90 -94.04 -4.21 -11.83 13.57
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.25 0.22 0.38 0.38 0.39 0.48 0.84
Accounts Receivable Turnover		 0.00 4.30 7.16 11.10 7.88 9.07 15.42 35.32
Inventory Turnover		 0.00 6.34 6.31 9.23 6.42 5.94 6.23 7.92
Fixed Asset Turnover		 0.00 0.72 1.92 4.97 3.26 2.80 3.59 6.25
Accounts Payable Turnover		 0.00 3.02 1.85 2.11 1.72 1.64 1.53 3.83
Days Sales Outstanding (DSO)		 0.00 84.79 50.97 32.87 46.30 40.24 23.66 10.33
Days Inventory Outstanding (DIO)		 0.00 57.57 57.81 39.53 56.84 61.47 58.60 46.06
Days Payable Outstanding (DPO)		 0.00 121.01 196.78 173.00 212.16 222.51 239.27 95.42
Cash Conversion Cycle (CCC)		 0.00 21.34 -88.01 -100.60 -109.02 -120.80 -157.01 -39.03
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 296 290 4,363 3,833 2,718 2,378 1,655
Invested Capital Turnover		 0.00 2.25 3.07 1.42 0.95 1.32 2.20 5.44
Increase / (Decrease) in Invested Capital		 0.00 296 -6.16 4,073 -531 -1,115 -340 -723
Enterprise Value (EV)		 0.00 2,795 -734 37,505 6,985 10,285 9,251 16,570
Market Capitalization		 1,496 1,496 4,272 39,756 8,504 12,576 11,143 19,258
Book Value per Share		 $0.00 ($2.81) $7.02 $4.19 $3.13 $2.97 $2.27 $2.29
Tangible Book Value per Share		 $0.00 ($2.85) $6.90 $4.10 $3.04 $2.56 $1.94 $1.97
Total Capital		 0.00 723 5,575 6,877 6,482 6,653 5,947 6,160
Total Debt		 0.00 312 280 263 1,130 1,536 1,662 1,817
Total Long-Term Debt		 0.00 243 253 263 669 796 776 942
Net Debt		 0.00 -93 -5,006 -2,251 -1,519 -2,291 -1,892 -2,688
Capital Expenditures (CapEx)		 112 263 120 357 609 294 282 444
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -97 -361 2,566 959 -200 -843 -2,324
Debt-free Net Working Capital (DFNWC)		 0.00 308 4,924 4,836 3,276 3,333 2,238 1,610
Net Working Capital (NWC)		 0.00 239 4,897 4,836 2,815 2,593 1,352 735
Net Nonoperating Expense (NNE)		 31 150 -42 40 441 388 155 -114
Net Nonoperating Obligations (NNO)		 0.00 -115 -5,006 -2,251 -1,519 -2,399 -1,907 -2,688
Total Depreciation and Amortization (D&A)		 14 33 67 131 205 297 352 427
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -28.98% -40.16% 77.90% 24.64% -4.63% -15.05% -21.19%
Debt-free Net Working Capital to Revenue		 0.00% 92.32% 547.80% 146.84% 84.13% 77.14% 39.98% 14.68%
Net Working Capital to Revenue		 0.00% 71.64% 544.84% 146.84% 72.29% 60.01% 24.15% 6.70%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($6.48) ($2.96) ($5.34) ($5.96) ($3.06) ($0.60)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 1.58B 1.71B 1.71B 1.74B 1.89B 1.90B
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($6.48) ($2.96) ($5.34) ($5.96) ($3.06) ($0.60)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 1.58B 1.71B 1.71B 1.74B 1.89B 1.90B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($6.48) ($2.96) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 754.27M 1.64B 1.72B 1.89B 1.90B 1.91B
Normalized Net Operating Profit after Tax (NOPAT)		 -173 -380 -462 -723 -884 -1,074 -639 -277
Normalized NOPAT Margin		 -12,221.76% -114.01% -51.43% -21.94% -22.69% -24.85% -11.40% -2.53%
Pre Tax Income Margin		 -14,411.94% -159.04% -46.73% -23.05% -33.95% -33.88% -14.27% -1.51%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 -250.49 -117.08 -126.56 -110.53 -76.18 -41.54 -19.19 -6.42
NOPAT to Interest Expense		 -203.75 -82.66 -133.87 -83.23 -46.10 -28.37 -13.55 -5.11
EBIT Less CapEx to Interest Expense		 -382.73 -174.28 -161.37 -151.65 -107.94 -49.31 -25.16 -14.59
NOPAT Less CapEx to Interest Expense		 -335.98 -139.85 -168.69 -124.35 -77.86 -36.14 -19.53 -13.27
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for XPENG

No quarterly metrics and ratios for XPENG are available.


Financials Breakdown Chart

Frequently Asked Questions About XPENG's Financials

When does XPENG's financial year end?

According to the most recent income statement we have on file, XPENG's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has XPENG's net income changed over the last 7 years?

XPENG's net income appears to be on an upward trend, with a most recent value of -$162.94 million in 2025, falling from -$203.60 million in 2018. The previous period was -$793.26 million in 2024. See where experts think XPENG is headed by visiting XPENG's forecast page.

What is XPENG's operating income?
XPENG's total operating income in 2025 was -$396.31 million, based on the following breakdown:
  • Total Gross Profit: $2.07 billion
  • Total Operating Expenses: $2.47 billion
How has XPENG's revenue changed over the last 7 years?

Over the last 7 years, XPENG's total revenue changed from $1.41 million in 2018 to $10.97 billion in 2025, a change of 776,470.1%.

How much debt does XPENG have?

XPENG's total liabilities were at $10.41 billion at the end of 2025, a 47.7% increase from 2024, and a 1,034.9% increase since 2019.

How much cash does XPENG have?

In the past 6 years, XPENG's cash and equivalents has ranged from $279.53 million in 2019 to $4.49 billion in 2020, and is currently $2.48 billion as of their latest financial filing in 2025.

How has XPENG's book value per share changed over the last 7 years?

Over the last 7 years, XPENG's book value per share changed from 0.00 in 2018 to 2.29 in 2025, a change of 228.7%.


Related Companies

Financial statements for NYSE:XPEV last updated on 4/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel